Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)
372.20
-4.60 (-1.22%)
May 27, 2026, 3:29 PM IST
NSE:ADVENZYMES Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 7,458 | 6,369 | 6,239 | 5,406 | 5,294 |
Other Revenue | 348.32 | - | - | - | - |
| 7,806 | 6,369 | 6,239 | 5,406 | 5,294 | |
Revenue Growth (YoY) | 22.56% | 2.09% | 15.39% | 2.13% | 5.49% |
Cost of Revenue | 1,930 | 1,653 | 1,576 | 1,420 | 1,181 |
Gross Profit | 5,876 | 4,716 | 4,663 | 3,987 | 4,113 |
Selling, General & Admin | 1,623 | 1,501 | 1,355 | 1,217 | 1,099 |
Other Operating Expenses | 1,615 | 1,269 | 1,260 | 1,163 | 999.22 |
Operating Expenses | 3,638 | 3,136 | 2,967 | 2,730 | 2,448 |
Operating Income | 2,238 | 1,580 | 1,695 | 1,257 | 1,665 |
Interest Expense | -26.28 | -35.57 | -29.28 | -24.21 | -17.96 |
Interest & Investment Income | - | 198.06 | 133.26 | 94.83 | 4.04 |
Currency Exchange Gain (Loss) | - | 9.75 | 5.49 | 13.02 | 2.46 |
Other Non Operating Income (Expenses) | - | 58.93 | 93.38 | 36.78 | 35.43 |
EBT Excluding Unusual Items | 2,212 | 1,811 | 1,898 | 1,377 | 1,689 |
Gain (Loss) on Sale of Investments | - | 58 | 86.13 | -27.24 | - |
Gain (Loss) on Sale of Assets | - | 2.29 | -3.05 | -7.51 | 11.5 |
Asset Writedown | - | - | - | -6.87 | - |
Legal Settlements | - | - | -151.32 | - | - |
Other Unusual Items | 113.59 | 1.98 | 48.2 | 68.27 | 10.26 |
Pretax Income | 2,325 | 1,874 | 1,878 | 1,404 | 1,711 |
Income Tax Expense | 589.28 | 533.9 | 508.7 | 365.22 | 472.59 |
Earnings From Continuing Operations | 1,736 | 1,340 | 1,370 | 1,039 | 1,238 |
Minority Interest in Earnings | -48.89 | -28.59 | -36.46 | 17.73 | -42.17 |
Net Income | 1,687 | 1,311 | 1,333 | 1,056 | 1,196 |
Net Income to Common | 1,687 | 1,311 | 1,333 | 1,056 | 1,196 |
Net Income Growth | 28.68% | -1.64% | 26.19% | -11.66% | -18.06% |
Shares Outstanding (Basic) | 112 | 112 | 112 | 112 | 112 |
Shares Outstanding (Diluted) | 112 | 112 | 112 | 112 | 112 |
Shares Change (YoY) | 0.04% | 0.10% | 0.06% | -0.05% | - |
EPS (Basic) | 15.08 | 11.72 | 11.92 | 9.45 | 10.70 |
EPS (Diluted) | 15.06 | 11.71 | 11.92 | 9.45 | 10.68 |
EPS Growth | 28.61% | -1.76% | 26.17% | -11.54% | -18.10% |
Free Cash Flow | 1,045 | 1,087 | 990.56 | 1,023 | 941.75 |
Free Cash Flow Per Share | 9.33 | 9.71 | 8.85 | 9.14 | 8.42 |
Dividend Per Share | - | 5.200 | 5.100 | 1.000 | 1.000 |
Dividend Growth | - | 1.96% | 410.00% | - | 11.11% |
Gross Margin | 75.28% | 74.05% | 74.74% | 73.74% | 77.69% |
Operating Margin | 28.67% | 24.81% | 27.18% | 23.25% | 31.45% |
Profit Margin | 21.61% | 20.59% | 21.37% | 19.54% | 22.59% |
Free Cash Flow Margin | 13.39% | 17.07% | 15.88% | 18.91% | 17.79% |
EBITDA | 2,639 | 1,839 | 1,948 | 1,507 | 1,918 |
EBITDA Margin | 33.81% | 28.88% | 31.22% | 27.87% | 36.23% |
D&A For EBITDA | 400.93 | 259.24 | 252.33 | 249.92 | 252.95 |
EBIT | 2,238 | 1,580 | 1,695 | 1,257 | 1,665 |
EBIT Margin | 28.67% | 24.81% | 27.18% | 23.25% | 31.45% |
Effective Tax Rate | 25.34% | 28.49% | 27.08% | 26.02% | 27.63% |
Revenue as Reported | 7,806 | 6,700 | 6,605 | 5,661 | 5,358 |
Advertising Expenses | - | 75.56 | 62.19 | 63.96 | 55.92 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.